Jump to content
  • Sign Up
0
Scott Adams

Celiac disease vax does well in Ph1; Washington pushes for higher vax rates; - FierceVaccines

Rate this topic

Recommended Posts

Celiac disease vax does well in Ph1; Washington pushes for higher vax rates;

FierceVaccines

Nexvax2, ImmusanT's celiac disease vaccine, performed well in Phase I testing, showing good safety and tolerability in patients. The vaccine focuses on three peptides found in gluten that are harmful to celiac sufferers. The company plans to start ...

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×